SARS-CoV-2 Infection
Showing NaN - NaN of 8
SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)
Completed
- SARS-CoV-2 Infection
- Moderna COVID-19 Vaccine
-
Birmingham, Alabama
- +50 more
Dec 1, 2022
COVID-19, SARS-CoV-2 Infection Trial in United States (NVX-Cov2373)
Active, not recruiting
- COVID-19
- SARS-CoV-2 Infection
-
Long Beach, California
- +30 more
Jul 18, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022
Covid19, SARS-CoV-2 Infection Trial in Iowa City, Saint Louis (GC4419, Placebo)
Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)
Completed
- Covid19
- +7 more
- Theophylline Powder
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Feb 1, 2022
Anosmia, Covid19, Ageusia Trial in Saint Louis (Smell Training)
Active, not recruiting
- Anosmia
- +6 more
- Smell Training
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Apr 2, 2021